For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| 160 mg Telmisartan | 60 patients will receive 160 of Telmisartan (2 80 mg tablets) for 101 days Telmisartan | 6 | None | 8 | 29 | 24 | 29 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Pain | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hospitalization | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Respiratory Failure | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Primary Graft Failure | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| GVHD (Oral) | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| GVHD (Skin) | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| GVHD (Skin/Liver) | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| H Pylori | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Hemorrhagic cystitis | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Hyperbilirubinemia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Hypercalcemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hyperglycemia (Intermittent) | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hyperkalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Hypertension (Intermittent) | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Hypoglycemia (intermittent) | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hypomagnesemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Infection (Kidney) | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Infection/Infestation | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Influenza | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Laryngeal mucositis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Lethargy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Malaise | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Mucositis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Nausea (Intermittent) | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Neutrophil Count Decreased | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Nocturia | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Pruritus | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Rash (Erythematous) | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Rash on Upper Back | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Respiratory infection (HAP) | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Right lower quadrant pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Sacral Decub | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Streptococcus mitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Swelling R knee | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Syncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Urinary frequency | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Vaginal abscess | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Weakness | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Weight Loss | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Abdominal Cramping | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Abdominal Pail | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Acute GVHD | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Acute GVHD (GI) | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Acute GVHD (Liver) | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Acute GVHD (Skin and GI) | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Acute GVHD (Skin) | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Acute Kidney Injury | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Acute Mental Status Change | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Adeno Viremia | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Anorexia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Anxiety | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| BK Viremia | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Bloating | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Chills | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Chronic GVHD | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Chronic GVHD (skin/liver, ocular, oral mucosa) | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| CMV Reactivation | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| CMV Viremia | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Creatinine increased | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Cystitis | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Deep vein thrombosis | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Delayed Engraftment | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Diarrhea (Intermittent) | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Dizziness (Intermittent) | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Dry eyes | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Dry Mouth | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Dysgeusia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Dysphagia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Dyspnea on Exertion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Dysuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Early Satiety | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Edema BLE | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Epstein-Barr Virus | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Erythema | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Erythroderma | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Flatulence | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Gastroesophageal Reflux Disease | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Generalized Weakness | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| GVHD (GI) | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| GVHD (Liver) | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |